Thumbnail

Echocardiography shows smoking is even more damaging to the heart than previously believed

Compared to the individuals without a history of smoking, both current and former smokers had thicker, weaker and heavier hearts.

Myocarditis risk higher after COVID-19 infection than after vaccination, new study of 43 million patients confirms

The new analysis, published in Circulation, confirmed that vaccine-related myocarditis is incredibly rare.

Thumbnail

NSAID use may not be safe for older patients with type 2 diabetes

The new analysis, based on data from more than 330,000 patients, is scheduled to be presented during ESC Congress 2022. 

Three systems for left ventricular pacing during TAVR, modified TAVR valve delivery wire, the Opsens Savvy wire, and the Teleflex Wattson wire.

VIDEO: Use of temporary left ventricular pacing during TAVR procedures

Philippe Genereux, MD, medical director of the structural heart disease program at Morristown Medical Center, discusses the various options used for temporary pacing of the heart during transcatheter aortic valve replacement (TAVR) procedures.

Thumbnail

Medical marijuana linked to a higher risk of heart rhythm issues

The new analysis, presented at ESC Congress 2022, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. 

Study the signs: The most common symptoms of 6 cardiovascular diseases

A new scientific statement details the most common symptoms associated with heart attacks, heart failure and other cardiac conditions. Importantly, the authors wrote, clinicians must remember that symptoms can vary between men and women. 

PET imaging uncovers a surprising new way COVID-19 affects the heart

A new study in JACC: Cardiovascular Imaging focuses on a potential new side effect of COVID-19, highlighting the continued importance of monitoring these patients going forward. 

Thumbnail

American Heart Association and Cardiovascular Research Foundation announce a new annual meeting collaboration

“Harnessing the strengths of our two pioneering organizations with extensive experience in translating the latest scientific breakthroughs into practical therapies is crucial," says AHA CEO Nancy Brown.